Cubist Pharmaceuticals (CBST) to be Acquired by Merck in $9.5B Deal
December 08, 2014 at 09:23 AM EST
Shares of Cubist Pharmaceuticals Inc. (CBST) were up +26.66 or +35.85 percent to $101.02 per share in this morning’s premarket, after news broke late Friday that the company was in acquisition talks with Merck & Co. MRK. The deal, which was just announced this morning, could be worth as much as $9.5 billion. Cubist stock Read the full article... Read the rest of Cubist Pharmaceuticals (CBST) to be Acquired by Merck in $9.5B Deal at InvestorGuide.com .